Shots:
- Roche allied with Moderna to utilize the Elecsys anti-SARS-CoV-2 S Ab test in mRNA-1273 study. The collaboration will facilitate the quantitative measurement of SARS-CoV-2 Abs and help to establish a correlation b/w vaccine-induced protection and levels of anti-RBD Abs
- The alliance follows US FDA’s EUA for the Elecsys anti-SARS-CoV-2 S Ab test. Moderna’s vaccine is in late-stage trials with 30,000+ participants, showed the efficacy of 94% in preventing COVID-19, and is designed to trigger an Ab response to proteins found on the coronavirus spike’s receptor-binding domain
- Elecsys Anti-SARS-CoV-2 is an immunoassay for the qualitative, in vitro detection of Abs (including IgG) to SARS-CoV-2
Click here to read full press release/ article | Ref: Roche | Image: The Conversation
The post Roche Collaborate with Moderna to include SARS-CoV-2 Ab Test in COVID-19 Vaccine Trials first appeared on PharmaShots.
